Recombinant Human TDP-43 protein (His Tag)
种属
Human
纯度
>90 %, SDS-PAGE
标签
His Tag
生物活性
未测试
验证数据展示
产品信息
纯度 | >90 %, SDS-PAGE |
内毒素 | <0.1 EU/μg protein, LAL method |
生物活性 | Not tested |
来源 | HEK293-derived Human TDP-43 protein Met1-Thr103 (Accession# Q13148-1) with a His tag at the C-terminus. |
基因ID | 23435 |
蛋白编号 | Q13148-1 |
预测分子量 | 12.5 kDa |
SDS-PAGE | 14-17 kDa, reducing (R) conditions |
组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
TARDBP was firstly found as a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. It was also reported to regulate alternate splicing of the CFTR gene. Neumann et al. (2006) found that a hyperphosphorylated, ubiquitinated, and cleaved form of TARDBP, known as pathologic TDP43, is the major disease protein in ubiquitin-positive, tau-, and alpha-synuclein-negative frontotemporal dementia (FTLD-U) and in Amyotrophic lateral sclerosis (ALS).
参考文献:
1. Neumann M, et al. (2006) Science. 314(5796):130-3. 2. Foulds PG, et al. (2006) Acta Neuropathol. 118(5):647-58. 3. Guo W, et al. (2011) Nat Struct Mol Biol. 18(7):822-30. 4. Dharmalingam K, et al. (2012) J Ethnopharmacol. 139(2):657-63.